Cell Therapy for Pediatric Malignancies


Date
Wednesday, July 6, 2016 - Thursday, July 6, 2017 12:00 AM   Online, IN

Objectives

At the conclusion of this activity, participants should be able to:

  1. Understand how the immune system can be manipulated to attack cancer cells;
  2. Identify cell therapy approaches for pediatric malignancies;
  3. Recall successes and challenges of T-cell therapies for cancer

Accreditation

Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Indiana University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Indiana University School of Medicine (IUSM) must demonstrate balance, independence, objectivity, and scientific rigor.  All faculty, authors, editors, and planning committee members participating in an IUSM-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

The planning committee and those in a position to control the content of this activity have disclosed no relevant financial relationships.

This CME activity does not have any commercial support.